Antibacterial compounds focusing on LsrK kinase
Researchers at the University of Eastern Finland have developed antibacterial compounds based on the action of LsrK kinase...
List view / Grid view
Researchers at the University of Eastern Finland have developed antibacterial compounds based on the action of LsrK kinase...
The Tn antigen appears in around 90 percent of cancers, and its structure is greatly affected by the addition of water molecules...
Researchers have found that moss could be more medically beneficial than tetrahydrocannabinol (THC) which is being used illegally to treat various diseases...
An experimental vaccine tested on mice could one day replace common blood thinners that are taken orally, such as aspirin...
Scientists in the U.S. have developed molecules, termed cyclic peptoids, that block the action of genes that drive the growth of therapy-resistant prostate cancer, according to a new study.
Researchers at Tokyo University have investigated the role of the Atg2 protein in the process of autophagy to aid drug discovery into neurodegeneration...
Researchers developed a novel DNA influenza vaccine based on four micro-consensus antigenic regions selected to represent the diversity of seasonal H3N2 viruses...
The action of a venomous snakebite from vipers could be treated using a flavonoid called rutin, an inexpensive plant based compound...
Stevens researchers design and develop a new class of molecules for breast cancer therapy...
A novel hybrid approach has revealed a 3D structure of a protein fragment that could serve as a drug target in treating stroke patients...
Using sugar molecules researchers have developed a new vaccine for hay fever that may reduce treatment times and increase the effectiveness of treatments...
New approach could prolong survival and trigger an immune...
A research team has developed a nano-platform technology that works in combination with existing chemotherapeutic drugs that may reverse drug-resistance in renal cell carcinoma...
Cancer cells have been found to evade immunotherapy by hiding behind human leukocyte antigens, with researchers identifying therapies to prevent relapse...
Women with ovarian cancer could in future benefit from a combined therapy using PD-1 and CTLA-4 as shown through the results of this Phase II trial...